Transgene competitorsClear all

Transgene's top competitors include EpiVax and Synthace.

Save Comparison	Transgene Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.	EpiVax EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.	Synthace Synthace produces bio-based chemical products through the application of synthetic biology.
Founding Date	Founding Date N/A	Founding Date 1998	Founding Date 2011
Type	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech	Tags Healthcare biotech	Tags Healthcare biotech
Locations	Locations Illkirch, FR HQ Shanghai, CN Lyon, FR Boston, US	Locations Providence, US HQ	Locations London, GB HQ Cambridge, US
Employees	Employees 1392% increase	Employees 343% increase	Employees 77
Twitter followers	Twitter followers 1.4 k	Twitter followers 379	Twitter followers 1.6 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 14	Number of tweets (last 30 days) 2	Number of tweets (last 30 days) 29
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 2.5	Average likes per tweet (last 30 days) 0.5	Average likes per tweet (last 30 days) 1.4
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 71.43%	Percentage of tweets with engagement (last 30 days) 50%	Percentage of tweets with engagement (last 30 days) 72.41%
Alexa Website Rank	Alexa Website Rank 221574	Alexa Website Rank 361738	Alexa Website Rank 523161
Employee Rating	Employee Rating 4.4	Employee Rating 3.9	Employee Rating N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 55k (about 8 years ago)	Latest funding round $ 25.6m (about 2 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 3.2m	Total funding raised $ 41.8m